Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/1998
06/11/1998CA2224131A1 Novel human 11 cb splice variant
06/10/1998EP0846763A2 A protein phosphatase 1 binding protein, R5
06/10/1998EP0846693A1 N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
06/10/1998EP0846688A1 New imidazoline derivatives having affinity for the imidazoline receptor
06/10/1998EP0846118A1 Cyclic gmp-specific phosphodiesterase inhibitors
06/10/1998EP0846108A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
06/10/1998EP0845992A1 Method of promoting angiogenesis
06/10/1998EP0845943A1 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits
06/10/1998EP0831817A4 Antigen-processing cell-targeted conjugates
06/10/1998EP0684958B1 Polymers containing guanidino groups for use in therapy
06/10/1998EP0674508B1 4-guanidinobutyramide for improving blood circulation
06/10/1998CN1184112A Inositolglycans having insulin-like action
06/10/1998CN1184105A Substituted thiazolidine derivatives and pharmaceutical compositions containing them and use thereof
06/10/1998CN1183966A Chinese medicine for regulating blood lipoid and its production process
06/10/1998CN1038680C Dihydronaphtho £1, 2-b| pyrane derivative and its producing process and use
06/09/1998US5763739 Genetic engineering
06/09/1998US5763611 Treating osteoporosis, rheumatoid arthritis
06/09/1998US5763571 Amino acid sequences which inhibit binding
06/09/1998US5763569 Polypeptides as calcium receptors to generate antibodies
06/09/1998US5763567 Human amino acid sequences which can bind to and/or neutralize heparin
06/09/1998US5763484 Metabolites of linoleic acid and a-linolenic acid
06/09/1998US5763467 Hypoglycemic hydroxyurea derivatives
06/09/1998US5763433 Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof
06/09/1998US5763414 Administering to mammal to treat hypercholesterolemia
06/09/1998US5763399 Revitalizing tissues with growth factor
06/09/1998US5763396 Method of treating or preventing type 1 diabetes by oral administration of insulin
06/09/1998US5763392 Nutritional supplyment for reducing blood glucose concentration
06/09/1998US5763195 Method and compositions for making ACSF and ACSF antagonists
06/09/1998US5762936 Antioxidant derived from lentil and its preparation and uses
06/09/1998US5762935 Anti-inflammatory and infection protective effects of sesamin-based lignans
06/04/1998WO1998023959A2 Diagnosis and treatment of insulin-dependent diabetes mellitus
06/04/1998WO1998023740A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
06/04/1998WO1998023613A1 Fused bicyclic pyrimidine derivatives
06/04/1998WO1998023603A1 Dimesylate salts of neuropeptide y ligands
06/04/1998WO1998023593A1 Apo b-secretion/mtp inhibitory amides
06/04/1998WO1998023277A1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesteremic agents
06/04/1998WO1998023275A1 Use of mixtures of active substances for the production of hypocholesteremic agents
06/04/1998WO1998023274A1 Androgenic and bisphosphonic agents coadministered to treat diseases
06/04/1998WO1998023170A1 Process for obtaining plant peptones with a high hydrolysis degree and applications thereof
06/04/1998CA2273341A1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesterolemic preparations
06/04/1998CA2272754A1 Use of mixtures of active substances for the production of hypocholesterolemic agents
06/04/1998CA2272345A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
06/04/1998CA2271664A1 Androgenic and bisphosphonic agents coadministered to treat diseases
06/04/1998CA2223541A1 New imidazoline derivatives, preparation process and the pharmaceutical compositions containing them
06/03/1998EP0845732A2 Method for assessing oxidative stress and its control in humans
06/03/1998EP0845475A1 Inositolglycans with insular activity
06/03/1998EP0845271A1 Dressing material having a calcium alginate matrix and method of making the same
06/03/1998EP0845216A1 A composition for administration to animals containing a tocopheryl phosphate
06/03/1998EP0845036A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/03/1998EP0845035A2 Urocortin peptides
06/03/1998EP0844997A1 Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation
06/03/1998EP0844882A1 Appetite regulating compositions
06/03/1998EP0844873A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same
06/03/1998CN1183785A Novel peptides and remedy for bone diseases contg. same as active ingredient
06/03/1998CN1183781A Novel heterocyclic compounds
06/03/1998CN1183717A Use of R-NSAID in protective composition for treatment of colorectal cancer
06/03/1998CN1183413A Thiazolidine derivative and its use for making medicanients
06/03/1998CN1183412A New benzopyran compounds, process for preparating them and pharmaceutical compositions containing them
06/03/1998CN1183276A Pharmaceutical compositions containing thiazolidine derivative and preparation process thereof
06/03/1998CN1183275A Use of thiazolidine derivative for making medicaments
06/03/1998CN1038585C Process for preparation of 2, 4 - and 2, 5 -substd. pyridine -N -oxides
06/02/1998US5760276 Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
06/02/1998US5760214 Bone resorption inhibition/osteogenesis promotion compound
06/02/1998US5760087 Glycylanilide derivatives, their preparation and their application in therapy
06/02/1998US5760084 Treating dermatological disorders
06/02/1998US5760082 Dietetic foods containing conjugated linoleic acids
06/02/1998US5760073 Treatment of central nervous system disorders
06/02/1998US5760047 Method for treatment of obesity using prolactin modulators and diet
06/02/1998US5760022 Pharmaceutical composition with improved bioavailability of inositol phosphate
06/02/1998US5759996 Reduce bone resorption, angiogenesis, and restenosis
06/02/1998US5759586 Mixture of sodium, potassium, magnesium and calcium (bi)carbonates and enzyme activators
06/02/1998US5759543 Application of a cell culture of a fusarium fungus strain producer for medical uses
06/02/1998US5759536 Use of fas ligand to supress T-lymphocyte-mediated immune responses
06/02/1998US5759534 Methods of treating disease using sertoli cells and allografts or xenografts
05/1998
05/29/1998CA2222828A1 Method for assessing oxidative stress and its control in humans
05/28/1998WO1998022506A1 Human kdel receptor
05/28/1998WO1998022479A1 Pharmaceutical formulations
05/28/1998WO1998022464A1 Xanthines and their therapeutic use
05/28/1998WO1998022457A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998WO1998022423A1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
05/28/1998WO1998022418A1 Substituted phenols and thiophenols useful as antioxidant agents
05/28/1998WO1998022138A1 Method for treating symptoms of diabetes
05/28/1998WO1998022128A1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
05/28/1998WO1998022109A1 Triaryl substituted imidazoles as glucagon antagonists
05/28/1998WO1998022108A1 Triaryl substituted imidazoles and methods of use
05/28/1998WO1998022105A1 Tabletted preparation
05/28/1998WO1998022101A2 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
05/28/1998WO1998021957A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998WO1998016184A3 Purine l-nucleosides, analogs and uses thereof
05/28/1998CA2633660A1 Method for treating symptoms of diabetes
05/28/1998CA2271963A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998CA2271941A1 Triaryl substituted imidazoles and methods of use
05/28/1998CA2271893A1 Triaryl substituted imidazoles as glucagon antagonists
05/28/1998CA2271767A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998CA2270407A1 Human kdel receptor
05/28/1998CA2268041A1 Xanthines and their therapeutic use
05/27/1998EP0844245A1 Benzopyran derivatives, process for their preparation and pharmaceutical compositions containing them
05/27/1998CN1183102A Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
05/27/1998CN1183045A Substances extracted from dictyotales, Preparation method therefor, and compositions containing same
05/27/1998CN1182746A Novel heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
1 ... 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 ... 1298